Renoprotective effects of GLP1R agonists and SGLT2 inhibitors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Nephrology
Link
http://www.nature.com/articles/nrneph.2017.140.pdf
Reference10 articles.
1. Muskiet, M. H. et al. GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes. Nat. Rev. Nephrol. 13, 605–628 (2017).
2. DeFronzo, R. A. et al. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition. Nat. Rev. Nephrol. 13, 11–26 (2017).
3. Mann, J. F. et al. Liraglutide and renal outcomes in type 2 diabetes. N. Engl. J. Med. 377, 839–848 (2017).
4. Wanner, C. et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N. Engl. J. Med. 375, 323–334 (2016).
5. Marso, S. P. et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med. 375, 311–322 (2016).
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule;Cell Metabolism;2024-06
2. Both partial inactivation as well as activation of NF-κB signaling lead to hypertension and chronic kidney disease;Nephrology Dialysis Transplantation;2024-04-13
3. Comparing the effects of empagliflozin and liraglutide on lipid metabolism and intestinal microflora in diabetic mice;PeerJ;2024-03-15
4. Simultaneous SGLT2 inhibition and caloric restriction improves insulin resistance and kidney function in OLETF rats;Molecular and Cellular Endocrinology;2023-01
5. Even high normal blood pressure affects live birth rate in women undergoing fresh embryo transfer;Human Reproduction;2022-09-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3